title: [THE USE OF PROBIOTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS].
abstract: The results of biological research of colon microbiota of patients with rheumatoid arthritis (RA) is in article presented. The signs of III degree dysbiosis, by reducing the concentration of Bacteroides spp., Bifidobacterium spp., Lactobacillus spp. populations, typical strain E. coli. But over growth of populations Klebsiella spp., Proteus spp., Staphylococcus spp., atypical forms of E. coli, Candida spp. The scheme for the correction of the colon microflora of patients with (RA) by was proposed bifiform. Increasing of populations concentration of Bifidobacterium spp., Bacteroides spp., Lactobacillus spp., typical E. coli, Enterococcus spp. and selective decontamination of Enterococcus (Hly+), Klebsiella spp., Proteus spp., Staphylococcus spp., lactosonegative and E.coli (Hly+) confirmed after using of this eubiotics.
authors.forename: O B
authors.initials: OB
authors.lastname: Kuchmak
authors.forename: S I
authors.initials: SI
authors.lastname: Klymnyuk
authors.forename: L B
authors.initials: LB
authors.lastname: Romanyuk
authors.forename: O V
authors.initials: OV
authors.lastname: Pokryshko
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000178:diet therapy* / Q000382:microbiology / Q000473:pathology; D058491:Bacterial Load; D001439:Bacteroides / Q000254:growth & development*; D001644:Bifidobacterium / Q000254:growth & development*; D002175:Candida / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D003106:Colon / Q000187:drug effects / Q000382:microbiology; D064806:Dysbiosis / Q000150:complications / Q000178:diet therapy* / Q000382:microbiology / Q000473:pathology; D004926:Escherichia coli / Q000254:growth & development*; D005260:Female; D006801:Humans; D007709:Klebsiella / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D007778:Lactobacillus / Q000254:growth & development*; D008297:Male; D064307:Microbiota / Q000502:physiology; D008875:Middle Aged; D019936:Probiotics / Q000627:therapeutic use*; D011511:Proteus / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D013210:Staphylococcus / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity